H-alpha-Me-L-Phe(3-NO2)-OH

H-alpha-Me-L-Phe(3-NO2)-OH is an L-configured, α-methylated phenylalanine derivative bearing a 3-nitro substituent on the aromatic ring and a free carboxylic acid for downstream coupling. The α-methyl stereocenter increases steric bias around the amino acid backbone, shaping peptide bond formation and conformational preferences in peptidomimetics and constrained analogs. The side-chain aryl group contains a nitro functional handle that can participate in electron-withdrawing effects during SAR work and can be chemically transformed through reduction or selective derivatization routes. The combination of a chiral amino acid core with an unprotected acid and a nitro-bearing aromatic side chain makes the compound a practical chiral intermediate for protected amino acid synthesis and for building peptide-like scaffolds with defined stereochemistry.

1. Peptide Synthesis

H-alpha-Me-L-Phe(3-NO2)-OH is applied in peptide coupling chemistry as an L-amino acid building block where the α-methyl group modulates sterics at the N-terminus during amide bond formation. The free carboxylic acid and amino functionality enable conversion to protected amino acid derivatives, supporting standard peptide coupling strategies after appropriate N-protection and, when required, side-chain or carboxyl activation. The 3-nitro phenyl side chain can be retained through peptide assembly to preserve electronic character, or transformed post-assembly to generate new functionality on the aromatic ring. The resulting nitro-containing peptide analogs and α-methylated sequences can be used to probe backbone effects and side-chain electronic contributions in peptide science.

2. Peptidomimetics And SAR

H-alpha-Me-L-Phe(3-NO2)-OH serves in structure-activity relationship studies and peptidomimetic design where the α-methyl stereocenter constrains local backbone geometry and can influence receptor binding conformations. The nitro-substituted aromatic ring provides an electron-withdrawing substituent that can be used as a tunable polar handle for SAR mapping, while the chiral amino acid framework maintains stereochemical fidelity in analog libraries. The compound can be incorporated into fragment-based or scaffold-focused synthesis to generate α-methylated aryl-containing analogs, followed by downstream nitro transformations to access reduced or functionalized aromatic variants. The stereodefined nature of the L-configuration supports consistent interpretation of how side-chain electronics and backbone substitution jointly affect molecular recognition.

3. Chemical Biology Probes

H-alpha-Me-L-Phe(3-NO2)-OH is suitable for chemical biology research where nitro-bearing aromatic residues can act as functional tags or transformation-ready motifs for probe generation. The α-methylated amino acid core can be used to incorporate sterically biased aromatic residues into peptide-like probes, supporting studies of binding-site tolerance to backbone substitution. The 3-nitro group can be chemically modified after incorporation to yield reduced amines or other reactive derivatives, enabling conjugation handles for labeling strategies. The compound's chiral amino acid structure also supports preparation of defined stereochemical standards for studies of biomolecular interactions and probe specificity.

4. Protected Amino Acid Chemistry

H-alpha-Me-L-Phe(3-NO2)-OH is used as a chiral intermediate in protected amino acid synthesis, where the free carboxylic acid and amino functionality can be converted into N-protected and, when needed, carboxyl-protected derivatives for controlled peptide assembly. The α-methyl stereocenter and nitro-bearing aromatic ring inform protecting-group selection by requiring conditions compatible with stereochemical integrity and nitro stability during protection/deprotection sequences. The resulting protected amino acid derivatives can be employed in iterative coupling workflows to access α-methylated peptide building blocks with predictable reactivity profiles. Downstream, the compound supports manufacturing-relevant intermediate preparation for fine chemical synthesis routes that require chiral, stereodefined amino acid inputs.

5. Process Chemistry Intermediate

H-alpha-Me-L-Phe(3-NO2)-OH functions as a process chemistry intermediate for industrial synthesis of nitro-substituted aromatic amino acid derivatives and peptide analog precursors. The combination of a single stereogenic α-carbon with a nitro-functional aromatic side chain enables route design that leverages selective transformations at the nitro group while maintaining the L-amino acid configuration. The free carboxylic acid supports conversion to activated forms or ester intermediates used in scalable downstream steps, including controlled incorporation into larger peptide-like molecules. The compound's defined structure supports consistent intermediate quality for specialty chemical production and for manufacturing workflows requiring chiral amino acid inputs with functional-group handles for later derivatization.

6. Analytical Research Standards

H-alpha-Me-L-Phe(3-NO2)-OH is applicable to analytical research as a stereochemically defined amino acid standard and reference material for method development involving amino acid derivatization and peptide hydrolysis products. The α-methyl substitution provides a distinctive chromatographic and mass spectrometric signature compared with non-methylated phenylalanine derivatives, improving specificity in targeted analyses. The 3-nitro group contributes characteristic ionization behavior and can be used to verify transformations in workflows that include nitro-to-amino conversion or aromatic functionalization. The compound can therefore support analytical characterization of peptide building block integrity, stereochemical consistency, and functional group retention during synthetic and process development.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry